Literature DB >> 31668192

Antibiotic-Resistant Community-Acquired Bacterial Pneumonia.

Jeffery Ho1, Margaret Ip2.   

Abstract

Antimicrobial resistance is a global concern, and prudent use of antibiotics is essential to preserve the current armamentarium of effective drugs. Acute respiratory tract infection is the most common reason for antibiotic prescription in adults. In particular, community-acquired pneumonia poses a significant health challenge and economic burden globally, especially in the current landscape of a dense and aging population. By updating the knowledge on the common antimicrobial-resistant pathogens in community-acquired respiratory tract infections, their prevalence, and resistance may pave the way to enhancing appropriate antibiotic use in the ambulatory and health care setting.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Community-acquired pneumonia; Haemophilus influenzae; Mycoplasma pneumoniae; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2019        PMID: 31668192     DOI: 10.1016/j.idc.2019.07.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  14 in total

1.  Qiangli Wuhu mixture alleviates LPS-induced pneumonia by inhibiting the TLR4/NF-κB/NLRP3 pathway: a study based on network pharmacology.

Authors:  Jie Tian; Xiao-Long Wang; Long-Cheng Wang; Fei Chen; Yun Tian; Li Ma; Chao-Yun Pan; Yan-Ping Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 2.  Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.

Authors:  Gang Chen; Kailiang Xu; Fangyuan Sun; Yuxia Sun; Ziyuan Kong; Bangjiang Fang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-06-30       Impact factor: 2.471

Review 3.  Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection.

Authors:  Alanna M Kelly; Rachel M McLoughlin
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

4.  Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota.

Authors:  Si-Lan Gu; Yiwen Gong; Jiaying Zhang; Yunbo Chen; Zhengjie Wu; Qiaomai Xu; Yunhui Fang; Jingxia Wang; Ling-Ling Tang
Journal:  Infect Drug Resist       Date:  2020-12-21       Impact factor: 4.003

Review 5.  [Current microbiological aspects of community respiratory infection beyond COVID-19].

Authors:  R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-03-22       Impact factor: 1.553

Review 6.  Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates.

Authors:  Felix Behrens; Teresa C Funk-Hilsdorf; Wolfgang M Kuebler; Szandor Simmons
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

7.  Protective effects of Re-yan-ning mixture on Streptococcus pneumonia in rats based on network pharmacology.

Authors:  Lizhu Han; Jing Kou; Kunxia Hu; Yunlan Wang; Zhishu Tang; Zhisheng Wu; Xiao Song
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 8.  Comparing Several Treatments with Antibiotics for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Fusheng Bai; Xinming Li
Journal:  Iran J Public Health       Date:  2021-06       Impact factor: 1.429

Review 9.  Insights From the Current Practice of Pneumococcal Disease Prevention for Diabetic Patients in Saudi Arabia.

Authors:  Raed Al-Dahash; Abdallah Kamal; Ashraf Amir; Ashraf Shabaan; Diaa Ewias; Hussam Jnaid; Mussa Almalki; Nabil Najjar; Najlaa Deegy; Saaed Khedr; Samia Bukhary
Journal:  Cureus       Date:  2022-03-29

10.  Emerging and Reemerging Infectious Diseases: Global Overview.

Authors:  Alimuddin Zumla; David S C Hui
Journal:  Infect Dis Clin North Am       Date:  2019-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.